Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2003 | 04-2003 | 01-2003 | 10-2002 | 07-2002 | |
| Sales | 152,200 | 186,000 | 194,600 | -7,400 | 235,100 |
| Cost of Goods | 95,200 | 113,600 | 125,500 | 30,900 | 202,100 |
| Gross Profit | 57,000 | 72,400 | 69,100 | -38,300 | 33,000 |
| Operating Expenses | 58,100 | 103,100 | 110,700 | 181,500 | 326,600 |
| Operating Income | -900 | -30,100 | -41,100 | -218,900 | -293,500 |
| Other Income | -1,700 | -500 | -500 | -12,600 | -4,000 |
| Pre-tax Income | -2,600 | -30,600 | -41,600 | -231,500 | -297,500 |
| Income Tax | N/A | N/A | N/A | -14,400 | 331,600 |
| Net Income Continuous | -2,600 | -30,600 | -41,600 | -217,100 | -629,100 |
| Net Income Discontinuous | -12,500 | 1,200 | 100 | N/A | N/A |
| Net Income | $-15,100 | $-29,400 | $-41,500 | $-381,900 | $-629,100 |
| EPS Basic Total Ops | -0.14 | -0.28 | -0.35 | -3.36 | -5.53 |
| EPS Basic Continuous Ops | 0.00 | -0.28 | -0.35 | -1.90 | -5.53 |
| EPS Basic Discontinuous Ops | -0.14 | 0.00 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | -0.14 | -0.28 | -0.35 | -3.36 | -5.53 |
| EPS Diluted Continuous Ops | 0.00 | -0.28 | -0.35 | -1.90 | -5.53 |
| EPS Diluted Discontinuous Ops | -0.14 | 0.00 | 0.00 | N/A | N/A |
| EBITDA(a) | $42,200 | $-11,900 | $-68,900 | $-176,100 | $-173,800 |